arginyl-glycyl-aspartic acid has been researched along with Adenocarcinoma, Alveolar in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Liu, Y; Sun, Y; Wang, M; Wang, W; Wu, F; Zhang, J; Zhang, L; Zhang, M; Zhang, Q; Zheng, T | 1 |
Feng, J; Feng, Y; Jia, HL; Li, HM; Li, XD; Li, ZY; Liu, B; Zhang, JY | 1 |
el-Solh, A; Kumar, NM; Lwebuga-Mukasa, JS; Nair, MP; Schwartz, SA | 1 |
3 other study(ies) available for arginyl-glycyl-aspartic acid and Adenocarcinoma, Alveolar
Article | Year |
---|---|
Tumor-targeting multi-shelled hollow nanospheres as drug loading platforms for imaging-guided combinational cancer therapy.
Topics: A549 Cells; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cell Survival; Combined Modality Therapy; Copper; Doxorubicin; Drug Delivery Systems; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Nanospheres; NIH 3T3 Cells; Oligopeptides; Phototherapy; Xenograft Model Antitumor Assays; Zinc | 2020 |
Imaging of bronchioloalveolar carcinoma in the mice with the αⅤβ3 integrin-targeted tracer (99m)Tc-RGD-4CK.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Animals; Cell Line; Humans; Integrin alphaVbeta3; Mice; Oligopeptides; Organotechnetium Compounds; Radionuclide Imaging; Tissue Distribution | 2013 |
An RGD containing peptide from HIV-1 Tat-(65-80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Gene Expression Regulation, Neoplastic; Gene Products, tat; Genes, p53; Humans; Lung Neoplasms; Oligopeptides; Peptide Fragments; Polymerase Chain Reaction; Proto-Oncogenes; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1997 |